YGYI

Youngevity earns a Neutral rating with conviction at two out of five, reflecting a composite score in the mid-40s. Fundamentals provide the strongest contribution at 51, supported primarily by a gross-margin subscore of 100 and secondary operating-margin and revenue-growth subscores of 66 and roughly 52. Regulatory positioning follows at 49, where the absence of enforcement hits offsets weak filing cadence. Market contribution stands at 40 because no quote is available through institutional pricing feeds, while editorial contribution trails at 30 amid no newsroom or brief activity in CIN newsroom coverage. The resulting pillar mix supports neither an upside call nor an outright bearish stance.

Licensed fundamentals data show year-over-year revenue growth of 1.9%, indicating limited top-line expansion despite a gross margin near 68.5%. That gross-margin profile is the clearest operating strength, but it fails to translate below the gross-profit line: operating margin remains negative at approximately 14.2%, EBITDA is negative by about $27.7 million, and net income reflects a loss approaching $47 million. A market capitalization below $0.4 million and a cash-burn ratio above 73 reinforce the stretched financial condition. Primary regulatory filings show no reported regulatory events across the past 90 or 180 days and no enforcement hits, supporting the regulatory pillar’s enforcement subscore of 80. However, no latest filing date is available, leaving cadence at a subscore of 25 and limiting confidence in financial visibility.

The principal catalyst sits within fundamentals, the highest-rated pillar. Youngevity’s gross margin provides a meaningful base for operating improvement if modest revenue growth accelerates and expense absorption narrows the negative operating margin. That conversion remains decisive because negative EBITDA and the substantial net loss preserve financing and execution pressure despite the strong gross-margin profile. Improved filing cadence would strengthen transparency, while renewed institutional pricing availability and CIN newsroom coverage would broaden confirmation across weaker pillars. The single most important signal to watch is sustained conversion of the near-68.5% gross margin into a materially less negative operating margin.